June 2019 PMID 30898608

Ticagrelor Versus Clopidogrel in Patients With STEMI Treated With Fibrinolysis: TREAT Trial.

Otavio Berwanger, Renato D Lopes, Diogo D F Moia, Francisco A Fonseca, Lixin Jiang, Shaun G Goodman, Stephen J Nicholls, Alexander Parkhomenko, Oleg Averkov, Carlos Tajer, Germán Malaga, Jose F K Saraiva, Helio P Guimaraes, Pedro G M de Barros E Silva, Lucas P Damiani

Download social card

Mentions

24
Peak: 4 in Jun 2019
across 5 sources since Mar 2019

Extended reach

119,224
potential audience

Total likes

71

Video views

1,604

Mentions per month

Mar 2019 – Sep 2022

Where it's discussed

  • X / Twitter10 posts
  • News8 articles
  • YouTube2 videos
  • Facebook2 posts
  • Blogs2 articles

AI synopsis

What people are saying

The discussions reflect a cautious interest in the study, with comments like questioning the clinical relevance of alternatives and mentioning the trial's relevance for specific cases like rescue procedures. The tone varies from skeptical to curious, with some posts referencing the study’s findings and implications without deep analysis, indicating a moderate level of engagement and perceived impact.

AgreementNeither agree nor disagree

The posts show varied opinions; some question the clinical significance, while others focus on potential applications.

InterestModerate interest

The discussion demonstrates moderate curiosity, especially regarding the implications for specific patient groups.

EngagementModerate engagement

Comments reference study details and potential clinical use, indicating a decent level of engagement.

ImpactNeutral impact

The overall impact appears limited, with the discussion leaning toward curiosity rather than definitive conclusions.

Abstract in brief

  • The study aimed to compare the effectiveness of ticagrelor versus clopidogrel in preventing cardiovascular events in patients under 75 who suffered from STEMI and received fibrinolytic therapy.
  • Results showed no significant difference in major cardiovascular outcomes between the two medications, with ticagrelor having a 6.7% event rate and clopidogrel 7.3%.
  • Overall, ticagrelor did not lead to fewer cardiovascular complications compared to clopidogrel post-treatment in the studied population.

Top posts

Most liked on X and Bluesky
Matias Rodriguez G
@matiasrg · X

Just a reminder: Is there a place for a more expensive and twice-a-day drug after STEMI pts treated with lytics instead of clopidogrel? No

Sep 5, 2022 · 5 likes · 1,398 followers View post →
Ignacio Seropian MD
@ISeropianMD · X

@MediCasos Muy buena iniciativa!

Aug 17, 2021 · 2 likes · 3 shares · 2,019 followers View post →
Jorge Bustos 
@JORARTU · X

Ticagrelor Versus Clopidogrel in Patients With STEMI Treated With Fibrinolysis: TREAT Trial https://t.co/8MY5tz9an0

Jun 7, 2019 · 2 likes · 1 share · 457 followers View post →
Pablo C.G.
@Otarrec · X

@AzuSuave https://t.co/HiqnThZvdg Quizás con una n mayor probablemente saldría con una P significativa. Aunque esto fue un estudio de no-inferioridad. No sé si en las próximas guías permitirán el Tica como AAG para FBN. A mi resulta interesante sobre todo para ICP rescate, o ICP precoz.

May 3, 2022 · 1 like · 333 followers View post →
Alejandro Castillo
@MediCasos · X

RT @ISeropianMD: @MediCasos Muy buena iniciativa!

Aug 17, 2021 · 3 shares · 110,277 followers View post →
ぽん@
@pharma_pon · X

Ticagrelor Versus Clopidogrel in Patients With STEMI Treated With Fibrinolysis: TREAT Trial. - PubMed - NCBI https://t.co/bvY1mFGiQm

Jun 18, 2019 · 986 followers View post →

All mentions

Matias Rodriguez G
@matiasrg · X

Just a reminder: Is there a place for a more expensive and twice-a-day drug after STEMI pts treated with lytics instead of clopidogrel? No

Sep 5, 2022 · 5 likes · 1,398 followers View post →
Pablo C.G.
@Otarrec · X

@AzuSuave https://t.co/HiqnThZvdg Quizás con una n mayor probablemente saldría con una P significativa. Aunque esto fue un estudio de no-inferioridad. No sé si en las próximas guías permitirán el Tica como AAG para FBN. A mi resulta interesante sobre todo para ICP rescate, o ICP precoz.

May 3, 2022 · 1 like · 333 followers View post →
Nathaly Avila Ronquillo
@ItsNathalyAvila · X

RT @ISeropianMD: @MediCasos Muy buena iniciativa!

Aug 17, 2021 · 3 shares · 76 followers View post →
Alejandro Castillo
@MediCasos · X

RT @ISeropianMD: @MediCasos Muy buena iniciativa!

Aug 17, 2021 · 3 shares · 110,277 followers View post →
Ignacio Seropian MD
@ISeropianMD · X

@MediCasos Muy buena iniciativa!

Aug 17, 2021 · 2 likes · 3 shares · 2,019 followers View post →
Ethical GmbH
@Ethicalgmbh · X

Ticagrelor Versus Clopidogrel in Patients With STEMI Treated With Fibrinolysis: TREAT Trial. - PubMed - NCBI https://t.co/G5oomjGjLv https://t.co/KYskAtNhAq

Sep 12, 2019 · 487 followers View post →
Adams CardioMD
@AdamsCardioMD · X

Ticagrelor Versus Clopidogrel in Patients With STEMI Treated With Fibrinolysis https://t.co/cZSxWnTmc6

Aug 29, 2019 · 607 followers View post →
ぽん@
@pharma_pon · X

Ticagrelor Versus Clopidogrel in Patients With STEMI Treated With Fibrinolysis: TREAT Trial. - PubMed - NCBI https://t.co/bvY1mFGiQm

Jun 18, 2019 · 986 followers View post →
Jorge Bustos 
@JORARTU · X

Ticagrelor Versus Clopidogrel in Patients With STEMI Treated With Fibrinolysis: TREAT Trial https://t.co/8MY5tz9an0

Jun 7, 2019 · 2 likes · 1 share · 457 followers View post →
Dataemia
@Dataemia · X

Ticagrelor Versus Clopidogrel in Patients With STEMI Treated With Fibrinolysis: TREAT Trial - https://t.co/vOsUvVMsxr https://t.co/UdHwaWQYxG

Jun 6, 2019 · 961 followers View post →